SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.
暂无分享,去创建一个
Jan Nyman | Bengt Bergman | Erik Holmberg | Per Bergström | Rolf Lewensohn | I. Lax | R. Lewensohn | S. Friesland | E. Holmberg | O. Brustugun | P. Bergström | B. Bergman | J. Nyman | J. Lund | Andreas Hallqvist | Ingmar Lax | Signe Friesland | Jo-Åsmund Lund | Odd-Terje Brustugun | A. Hallqvist
[1] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Lise Tremblay,et al. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non–Small-Cell Lung Cancer: CEPO Review and Recommendations , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] L. Kestin,et al. Stereotactic Radiotherapy Reduces Treatment Cost While Improving Overall Survival and Local Control Over Standard Fractionated Radiation Therapy for Medically Inoperable Non-Small-Cell Lung Cancer , 2011, American journal of clinical oncology.
[4] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[5] Yoshihiro Takai,et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Jan Nyman,et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] I. Lax,et al. Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience , 2015, Acta oncologica.
[8] Russ Hamilton,et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. , 2008, Cancer treatment reviews.
[9] C. Drake,et al. Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses , 2013, BioMed research international.
[10] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[11] Masahiro Hiraoka,et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.
[12] Philippe Lambin,et al. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] Joe Y. Chang,et al. Clinical Investigation : Thoracic Cancer Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly , 2012 .
[14] H. Geinitz,et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) , 2006, Acta oncologica.
[15] I. Lax,et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.
[16] Alfons G H Kessels,et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] John Cho,et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. , 2012, International journal of radiation oncology, biology, physics.
[18] Joe Y. Chang,et al. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[19] F. Sterzing,et al. Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] Umberto Ricardi,et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.
[21] H. Wakelee,et al. Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC). , 2013, Translational lung cancer research.
[22] J. Langendijk,et al. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[23] C. Brink,et al. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: An updated retrospective study on local failure and survival rates , 2013, Acta oncologica.
[24] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[25] D. de Ruysscher,et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] M. Baumann,et al. SABR in NSCLC--the beginning of the end or the end of the beginning? , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] S. Senan,et al. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] I. Lax,et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. , 2003, Lung cancer.
[29] Max Dahele,et al. Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] Ping Li,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[31] K. Johansson,et al. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients. , 2006, Lung cancer.